Compile Data Set for Download or QSAR
Report error Found 613 for UniProtKB: P10276
TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM323587(4-[(E)-2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2...)
Affinity DataEC50:  5.5nMAssay Description:Retinoid nuclear receptor activity is associated with transduction of the non-visual physiologic, pharmacologic, and toxicologic retinoid signals tha...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/25/2019
Entry Details
US Patent

LigandPNGBDBM31882(CHEMBL80992 | BMS184394-R)
Affinity DataKd:  1.60E+4nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31884(CHEMBL81273 | BMS184394-S)
Affinity DataKd:  7.50E+3nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31885(CHEMBL82089 | BMS184394)
Affinity DataKd:  7.50E+3nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31886(CHEMBL309282 | CD564)
Affinity DataKd:  118nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31887(Ch 80 | BMS181156)
Affinity DataKd:  0.400nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31888(CD666)
Affinity DataKd:  2.24E+3nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31889(BMS 961 | BMS961 | BMS270394)
Affinity DatapH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31890(BMS270395)
Affinity DatapH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31883(ALL-TRANS-RETINOIC ACID | SMR000058245 | cid_44479...)
Affinity DataKd:  0.400nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMed
LigandPNGBDBM31892(CHEMBL705 | 9-cis retinoic acid | alitretinoin | P...)
Affinity DataKd:  0.300nMpH: 7.9 T: 2°CAssay Description:Recombinant RAR protein expressed in E. coli was used in the direct binding assay. The apparent dissociation constants (Kd) were determined by the ch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2009
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM323588(Retinoic Acid | all-trans-retinoic acid | at-RA | ...)
Affinity DataEC50:  1.20nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM50526314(CHEMBL4459692 | US10752616, Code No. BHBA-001)
Affinity DataEC50:  26nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458121(US10752616, Code No. BHBA-002)
Affinity DataEC50:  136nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458124(US10752616, Code No. BHBA-003)
Affinity DataEC50:  160nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458133(US10752616, Code No. BHBA-005)
Affinity DataEC50:  130nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM50526313(CHEMBL4469143 | US10752616, Code No. BHBA-006)
Affinity DataEC50:  89nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM50526312(CHEMBL4449668 | US10752616, Code No. BHBA-007)
Affinity DataEC50:  16nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458145(US10752616, Code No. BHBA-008)
Affinity DataEC50:  17nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458150(US10752616, Code No. BHBA-009)
Affinity DataEC50:  32nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458152(US10752616, Code No. BHBA-010)
Affinity DataEC50:  25nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458158(US10752616, Code No. BHBA-011)
Affinity DataEC50:  26nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458165(US10752616, Code No. BHBA-012)
Affinity DataEC50:  67nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458201(US10752616, Code No. BHBA-013)
Affinity DataEC50:  140nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458233(US10752616, Code No. BHBA-014)
Affinity DataEC50:  12nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458240(US10752616, Code No. BHBA-015)
Affinity DataEC50:  23nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458251(US10752616, Code No. BHBA-016)
Affinity DataEC50:  18nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458259(US10752616, Code No. BHBA-017)
Affinity DataEC50:  56nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458260(US10752616, Code No. BHBA-018)
Affinity DataEC50:  150nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM50526315(CHEMBL4439399 | US10752616, Code No. BHBA-019)
Affinity DataEC50:  19nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458262(US10752616, Code No. BHBA-020)
Affinity DataEC50:  60nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM50526325(CHEMBL4438880 | US10752616, Code No. BHBA-021)
Affinity DataEC50:  30nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458264(US10752616, Code No. BHBA-022)
Affinity DataEC50:  77nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM50526327(CHEMBL4562084 | US10752616, Code No. BHBA-023)
Affinity DataEC50:  114nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458266(US10752616, Code No. BHBA-024)
Affinity DataEC50:  180nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458267(US10752616, Code No. BHBA-025)
Affinity DataEC50:  150nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458268(US10752616, Code No. BHBA-026)
Affinity DataEC50:  47nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458269(US10752616, Code No. BHBA-027)
Affinity DataEC50:  61nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458270(US10752616, Code No. BHBA-028)
Affinity DataEC50:  26nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458271(US10752616, Code No. BHBA-029)
Affinity DataEC50:  210nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458272(US10752616, Code No. BHBA-030)
Affinity DataEC50:  58nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458273(US10752616, Code No. BHBA-031)
Affinity DataEC50:  150nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458274(US10752616, Code No. BHBA-032)
Affinity DataEC50:  150nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458275(US10752616, Code No. BHBA-033)
Affinity DataEC50:  45nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458276(US10752616, Code No. BHBA-034)
Affinity DataEC50:  92nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458277(US10752616, Code No. BHBA-035)
Affinity DataEC50:  91nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458278(US10752616, Code No. BHBA-036)
Affinity DataEC50:  225nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458279(US10752616, Code No. BHBA-037)
Affinity DataEC50:  91nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458280(US10752616, Code No. BHBA-038)
Affinity DataEC50:  19nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

TargetRetinoic acid receptor alpha(Human)
Acucela

US Patent
LigandPNGBDBM458281(US10752616, Code No. BHBA-039)
Affinity DataEC50:  65nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
US Patent

Displayed 1 to 50 (of 613 total ) | Next | Last >>
Jump to: